ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $994,000 | -9.9% | 59,700 | -14.5% | 0.01% | -14.3% |
Q2 2018 | $1,103,000 | -29.5% | 69,800 | -43.3% | 0.01% | -26.3% |
Q1 2018 | $1,565,000 | -8.8% | 123,200 | -17.8% | 0.02% | -5.0% |
Q4 2017 | $1,716,000 | -15.3% | 149,900 | -9.3% | 0.02% | -20.0% |
Q3 2017 | $2,025,000 | – | 165,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |